Inovio Pharmaceuticals Inc (NAS:INO)
$ 4.19 0.18 (4.49%) Market Cap: 109.36 Mil Enterprise Value: 37.00 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 46/100

Q4 2018 Inovio Pharmaceuticals Inc Earnings Call Transcript

Mar 12, 2019 / 08:30PM GMT
Release Date Price: $42.72 (+1.14%)
Operator

Good afternoon, everyone, and welcome to the Inovio Fourth Quarter 2018 Financial Results Conference Call. (Operator Instructions) Please also note, today's event is being recorded. At this time, I'd like to turn the conference call over to Mr. Ben Matone, Director of Investor Relations. Sir, please go ahead.

Ben Matone
Inovio Pharmaceuticals, Inc. - Director of IR

Thank you, operator. Good afternoon, everyone, and thank you for joining the Inovio Pharmaceuticals Fourth Quarter and Full Year 2018 Corporate Earnings Conference Call. This call is being webcast live on our website, ir. Inovio.com and a replay will be available as indicated in our press release. During this call, we will conduct a question-and-answer segment, which will be reserved for equity research analysts.

Before we begin, I would like to remind everyone that on this call, we will make certain forward-looking statements that relate to our business, which include our plans to develop our DNA immunotherapy platform, in combination with our proprietary delivery devices, developments and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot